Canine and feline trefoil factor family peptides: Highly conserved molecules with some unique characteristics

Research in Veterinary Science

Volumn 85, Issue 1, 2008, Pages 68-73

  Campbell, B G ^a   Jabbes, M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Cat; Dog; TFF1; TFF2; TFF3; Trefoil peptide

Indexed keywords

COMPLEMENTARY DNA; RNA; TREFOIL PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CAT; CONTROLLED STUDY; DIMERIZATION; DNA SEQUENCE; DOG; GENE AMPLIFICATION; GENETIC CONSERVATION; HYDROPHOBICITY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION; RNA ISOLATION; RNA TRANSCRIPTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATS; COLON; CONSERVED SEQUENCE; DNA, COMPLEMENTARY; DOGS; GASTRIC MUCOSA; INTESTINAL MUCOSA; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PEPTIDES; POLYMORPHISM, GENETIC; RNA;

CANIS FAMILIARIS; FELIDAE; LOTUS; MAMMALIA; RODENTIA;

EID: 43649088515     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2007.08.008     Document Type: Article

References (35)

1. Balleine R.L., and Clarke C.L. Expression of the oestrogen responsive protein pS2 in human breast cancer. Histol. Histopath. 14 (1999) 571-578
2. Beck P.L., Wong J.F., Li Y., Swaminathan S., Xavier R.J., Devaney K.L., and Podolsky D.K. Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 126 (2004) 796-808
3. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., and Julie D. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31 (2003) 3497-3500
4. Colombel M., Dante R., Bouvier R., Ribieras S., Pangaud C., Marechal J.M., and Lasne Y. Differential RNA expression of the pS2 gene in the human benign and malignant prostatic tissue. J. Urol. 162 (1999) 927-930
5. Farrell J.J., Taupin D., Koh T.J., Chen D., Zhao C.M., Podolsky D.K., and Wang T.C. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J. Clin. Invest. 109 (2002) 193-204
6. Hauser F., Poulsom R., Chinery R., Rogers L.A., Hanby A.M., Wright N.A., and Hoffmann W. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc. Nat. Acad. Sci. USA 90 (1993) 6961-6965
7. Hoffmann W. Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol. Life Sci. 62 (2005) 2932-2938
8. Jergens A.E. Inflammatory bowel disease. Current perspectives. Vet. Clin. North Am. Small Anim. Pract. 29 (1999) 501-521 vii
9. Kirikoshi H., and Katoh M. Expression of TFF1, TFF2 and TFF3 in gastric cancer. Int. J. Oncol. 21 (2002) 655-659
10. Lee A.B., and Cooper T.A. Improved direct PCR screen for bacterial colonies: wooden toothpicks inhibit PCR amplification. Biotechniques 18 (1995) 225-226
11. Lefebvre O., Wolf C., Kedinger M., Chenard M.P., Tomasetto C., Chambon P., and Rio M.C. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J. Cell Biol. 122 (1993) 191-198
12. Lefebvre O., Chenard M.P., Masson R., Linares J., Dierich A., LeMeur M., Wendling C., Tomasetto C., Chambon P., and Rio M.C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274 (1996) 259-262
13. Lemercinier X., Muskett F.W., Cheeseman B., McIntosh P.B., Thim L., and Carr M.D. High-resolution solution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with the other members of the trefoil family of mammalian cell motility factors. Biochemistry 40 (2001) 9552-9559
14. Leung W.K., Yu J., Chan F.K., To K.F., Chan M.W., Ebert M.P., Ng E.K., Chung S.C., Malfertheiner P., and Sung J.J. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J. Pathol. 197 (2002) 582-588
15. Longman R.J., Thomas M.G., and Poulsom R. Trefoil peptides and surgical disease. Brit. J. Surg. 86 (1999) 740-748
16. Maruyama K., and Sugano S. Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene 138 (1994) 171-174
17. Mashimo H., Wu D.C., Podolsky D.K., and Fishman M.C. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274 (1996) 262-265
18. Mead D.A., Pey N.K., Herrnstadt C., Marcil R.A., and Smith L.M. A universal method for the direct cloning of PCR amplified nucleic acid. Biotechnology (NY) 9 (1991) 657-663
19. Muskett F.W., May F.E., Westley B.R., and Feeney J. Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): the intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins. Biochemistry 42 (2003) 15139-15147
20. Ohshio G., Suwa H., Kawaguchi Y., Imamura M., Yamaoka Y., Yamabe H., Matsumoto M., Yoshioka H., Hashimoto Y., and Takeda H. Differential expression of human spasmolytic polypeptide (trefoil factor family-2) in pancreatic carcinomas, ampullary carcinomas, and mucin-producing tumors of the pancreas. Dig. Dis. Sci. 45 (2000) 659-664
21. Plaut A.G. Trefoil peptides in the defense of the gastrointestinal tract. New Eng. J. Med. 336 (1997) 506-507
22. Playford R.J., Ghosh S., and Mahmood A. Growth factors and trefoil peptides in gastrointestinal health and disease. Curr. Opin. Pharmacol. 4 (2004) 567-571
23. Polshakov V.I., Williams M.A., Gargaro A.R., Frenkiel T.A., Westley B.R., Chadwick M.P., May F.E., and Feeney J. High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein. J. Mol. Biol. 267 (1997) 418-432
24. Poulsom R., Hanby A.M., Lalani E.N., Hauser F., Hoffmann W., and Stamp G.W. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J. Pathol. 183 (1997) 30-38
25. Sasaki M., Tsuneyama K., and Nakanuma Y. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab. Invest. 83 (2003) 1403-1413
26. Sherding R.G. Diseases of the intestine. In: Sherding R.G. (Ed). The Cat: Diseases and Clinical Management (1989), Churchill Livingstone, New York 955-1006
27. Suemori S., Lynch-Devaney K., and Podolsky D.K. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc. Nat. Acad. Sci. USA 88 (1991) 11017-11021
28. Tams T.R. Feline inflammatory bowel disease. Vet. Clin. North Am. Small Anim. Pract. 23 (1993) 569-586
29. Thim L., and May F.E. Structure of mammalian trefoil factors and functional insights. Cell Mol. Life Sci. 62 (2005) 2956-2973
30. Thim L., Madsen F., and Poulsen S.S. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur. J. Clin. Invest. 32 (2002) 519-527
31. Tomita M., Itoh H., Ishikawa N., Higa A., Ide H., Murakumo Y., Maruyama H., Koga Y., and Nawa Y. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. Biochem. J. 311 Pt 1 (1995) 293-297
32. Uchino H., Kataoka H., Itoh H., and Koono M. Expression of intestinal trefoil factor mRNA is downregulated during progression of colorectal carcinomas. J. Clin. Pathol. 50 (1997) 932-934
33. Withrow S.J., and MacEwen E.G. Small Animal Clinical Oncology. second ed. (1996), W.B. Saunders, Philadelphia
34. Wong W.M., Poulsom R., and Wright N.A. Trefoil peptides. Gut 44 (1999) 890-895
35. Yeh T.S., Jan Y.Y., Chiu C.T., Ho Y.B., Chen T.C., Lee K.F., Chan K.M., Hsu J.C., Hwang T.L., and Chen M.F. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma. Gut 51 (2002) 712-716